The oral insulin sensitizer, thiazolidinedione, increases plasma vascular endothelial growth factor in type 2 diabetic patients
- PMID: 11347762
- DOI: 10.2337/diacare.24.5.953
The oral insulin sensitizer, thiazolidinedione, increases plasma vascular endothelial growth factor in type 2 diabetic patients
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
